Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

被引：1
|
作者：
Hofer, Felix [1 ]
Hammer, Andreas [1 ]
Steinacher, Eva [1 ]
Baumer, Ulrike [1 ]
Kazem, Niema [1 ]
Koller, Lorenz [1 ]
Richter, Bernhard [1 ]
Hengstenberg, Christian [1 ]
Sulzgruber, Patrick [1 ]
Niessner, Alexander [1 ]
机构：
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2023年 / 9卷 / 06期
关键词：
D O I：
10.1093/ehjcvp/pvad022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：505 / 506
页数：2
相关论文
共 50 条
  • [41] Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?
    Halavina, Kseniya
    Bartko, Philipp E.
    Nitsche, Christian
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 910 - 911
  • [42] Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction A protocol for meta-analysis
    Fukuta, Hidekatsu
    Hagiwara, Hiromi
    Kamiya, Takeshi
    MEDICINE, 2021, 100 (51) : E28448
  • [43] A Sweet Solution for Heart Failure With Preserved Ejection Fraction: The Role of Sodium-Glucose Cotransporter-2 Inhibitors
    Salazar, Ruben A.
    Stroud, Steven C.
    DeFilippis, Ersilia M.
    CIRCULATION-HEART FAILURE, 2023, 16 (02) : 229 - 231
  • [44] Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction
    Martyn, Trejeeve
    Saef, Joshua
    Bansal, Agam
    Martinez, Kathryn A.
    Block-Beach, Hunter
    Hohman, Jessica
    Kapadia, Samir R.
    Desai, Milind Y.
    Estep, Jerry D.
    Albert, Nancy M.
    Starling, Randall C.
    Tang, W. H. Wilson
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (04) : 630 - 632
  • [45] Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion
    Hernandez, Michelle
    Sullivan, Ryan D.
    McCune, Mariana E.
    Reed, Guy L.
    Gladysheva, Inna P.
    DIAGNOSTICS, 2022, 12 (04)
  • [46] Sodium-glucose cotransporter type 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies
    Tomasoni, Daniela
    Stretti, Lorenzo
    Adamo, Marianna
    Metra, Marco
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (04) : 251 - 254
  • [47] Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction
    Vanhentenrijk, Simon
    Tang, W. H. Wilson
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 897 - 899
  • [48] Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Monzo, Luca
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Cal, Leonardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 341 : 56 - 59
  • [49] Sodium-glucose CO-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [50] The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction
    Brust-Sisti, Lindsay
    Rudawsky, Nicole
    Gonzalez, Jimmy
    Brunetti, Luigi
    PHARMACY, 2022, 10 (06)
12345